Investor Relations Captor Therapeutics ®
Contents of the resolutions passed by the Annual General Meeting of Captor Therapeutics S.A. after the resumption of the meeting on 14 July 2022.
Current Report No. 29/2022
Date of preparation: 14 July 2022
Subject: Contents of the resolutions passed by the Annual General Meeting of Captor Therapeutics S.A. after the resumption of the meeting on 14 July 2022.
Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information.
The Management Board of Captor Therapeutics S.A. (the "Company"), provides the contents of the resolutions passed by Ordinary General Meeting of the Company (the "OGM"), convened on 30 June 2022, sitting after adjournment on 14 July 2022, as well as the contents of draft resolutions 20 and 26, which were not passed by the OGM, as appended hereto.
At the same time the Company informs that OGM did not withdraw from consideration of any of the items of the planned agenda. No objections to the adopted resolutions were entered into the minutes.
Detailed legal basis:
§19 (1) items. 6, 7 and 9 of the RMF on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state